Adverum Biotechnologies logo

Adverum Biotechnologies Share Price (NASDAQ: ADVM)

$3.11

0.08

(2.64%)

Last updated on

Check the interactive Adverum Biotechnologies Stock chart to analyse performance

Adverum Biotechnologies stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.00
    Today's High:$3.11

    Day's Volatility :3.54%

  • 52 Weeks Low:$1.78
    52 Weeks High:$8.56

    52 Weeks Volatility :79.21%

Adverum Biotechnologies Stock Returns

PeriodAdverum Biotechnologies IncSector (Health Care)Index (Russel 2000)
3 Months
23.46%
3.6%
0.0%
6 Months
-27.88%
-7.7%
0.0%
1 Year
-55.62%
-12.6%
0.0%
3 Years
-73.21%
9.5%
-4.7%

Adverum Biotechnologies Inc Key Stats

Check Adverum Biotechnologies key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.03
Open
$3.0
Today's High
$3.11
Today's Low
$3.0
Market Capitalization
$63.8M
Today's Volume
$65.6K
52 Week High
$8.56
52 Week Low
$1.78
Revenue TTM
$1000.0K
EBITDA
$-172.2M
Earnings Per Share (EPS)
$-8.13
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-229.34%

Stock Returns calculator for Adverum Biotechnologies Stock including INR - Dollar returns

The Adverum Biotechnologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Adverum Biotechnologies investment value today

Current value as on today

₹50,097

Returns

₹49,903

(-49.9%)

Returns from Adverum Biotechnologies Stock

₹55,187 (-55.19%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Adverum Biotechnologies Stock

-73%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Adverum Biotechnologies Stock from India on INDmoney has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Adverum Biotechnologies Inc

  • Name

    Holdings %

  • BML Capital Management LLC

    14.57%

  • TCG Crossover Management, LLC

    8.56%

  • BlackRock Inc

    6.80%

  • Vanguard Group Inc

    4.21%

  • 5AM Venture Management, LLC

    2.58%

  • Goldman Sachs Group Inc

    2.37%

Analyst Recommendation on Adverum Biotechnologies Stock

Rating
Trend

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Adverum Biotechnologies(by analysts ranked 0 to 5 stars)

Adverum Biotechnologies Share Price Target

What analysts predicted

Upside of 527.01%

Target:

$19.50

Current:

$3.11

Adverum Biotechnologies share price target is $19.50, a slight Upside of 527.01% compared to current price of $3.11 as per analysts' prediction.

Adverum Biotechnologies Stock Insights

  • Price Movement

    In the last 1 month, ADVM stock has moved up by 25.5%
  • ADVM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 126.7%
  • ADVM vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 187.8%
  • Price to Sales

    ForADVM every $1 of sales, investors are willing to pay $62.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Adverum Biotechnologies Technicals Summary

Sell

Neutral

Buy

Adverum Biotechnologies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Adverum Biotechnologies Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Adverum Biotechnologies Inc logo
25.52%
-27.88%
-55.62%
-73.21%
-97.49%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Adverum Biotechnologies Inc

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec Ixo-vec, a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing BGTF-027 (AAV.7m8-L-opsin), a novel gene therapy product candidate designed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Ray Therapeutics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Organization
Adverum Biotechnologies
Employees
155
CEO
Dr. Laurent Fischer M.D.
Industry
Health Technology

Key Management of Adverum Biotechnologies Inc

NameTitle
Dr. Laurent Fischer M.D.
President, CEO & Director
Ms. Linda M. Rubinstein M.A.
CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Kishor Peter Soparkar J.D.
Chief Operating Officer
Dr. Setareh Seyedkazemi Pharm.D.
Chief Development Officer
Dr. Rabia Gurses Ozden M.D.
Chief Medical Officer
Dr. R. Andrew Ramelmeier Ph.D.
Chief Technology Officer
Dr. Romuald Corbau Ph.D.
Chief Scientific Officer
Ms. Aneta Ferguson
General Counsel
Ms. Dena House
Chief People Officer
Ms. Carla Fiankan
Senior Vice President of Regulatory Affairs

Important FAQs about investing in ADVM Stock from India :

What is Adverum Biotechnologies share price today?

Adverum Biotechnologies share price today is $3.11 as on at the close of the market. Adverum Biotechnologies share today touched a day high of $3.11 and a low of $3.00.

What is the 52 week high and 52 week low for Adverum Biotechnologies share?

Adverum Biotechnologies share touched a 52 week high of $8.56 and a 52 week low of $1.78. Adverum Biotechnologies stock price today i.e. is closed at $3.11, lower by 63.67% versus the 52 week high.

How to invest in Adverum Biotechnologies Stock (ADVM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adverum Biotechnologies on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adverum Biotechnologies Shares that will get you 0.4823 shares as per Adverum Biotechnologies share price of $3.11 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Adverum Biotechnologies Stock (ADVM) from India?

Indian investors can start investing in Adverum Biotechnologies (ADVM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Adverum Biotechnologies stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Adverum Biotechnologies share’s latest price of $3.11 as on August 30, 2025 at 1:29 am IST, you will get 3.2154 shares of Adverum Biotechnologies. Learn more about fractional shares .

What are the returns that Adverum Biotechnologies has given to Indian investors in the last 5 years?

Adverum Biotechnologies stock has given -97.49% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?